Skip to main content
The journey to ‘normal’: post-pandemic cancer care

The global pandemic has significantly disrupted health care around the world, including cancer diagnoses and treatments, leaving many patients waiting for care during an already anxious time. Now, as restrictions begin to ease, the work of managing the backlog of cases begins. As we journey to our new ‘normal’, what have we learned from the pandemic to guide our processes and prepare us for the next major event?

CONGRATULATIONS!

A huge congratulations to our CBG Division's Dr. Andrew Craig on obtaining a 5-year CIHR Project Grant entitled "Targeting TGF-beta signaling to achieve durable therapy responses in preclinical ovarian cancer models". 

PhD Candidate in Dr. Berman's lab, Chelsea Jackson, shares her passion for research and her cutting edge work in bladder cancer

PhD Candidate in Dr. Berman's lab @QueensCRI, Chelsea Jackson shares her passion for research and her cutting edge work in bladder cancer @QueensPathology

Measure Twice, Cut Once. Work by Drs. Jamaspishvili and Berman, just published in @JNCI_Now.

By more precisely measuring tumour suppressor gene expression, pathologists can more precisely identify patients whose #prostatecancer might need more aggressive treatment. @QueensCRI @virchow @queensu @OICR_news @QueensPathology @queensuResearch @OntarioPath @UMontreal @JohnsHopkins @usponline 

Subscribe to Research news